Kayne Anderson Rudnick Investment Management
SILK

Kayne Anderson Rudnick Investment Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-456,778
Closed -$6.85M – 989
2023
Q3 		$6.85M Sell
456,778
-897,930
-66% -$18.7M 0.02% 273
2023
Q2 		$44M Sell
1,354,708
-16,958
-1% -$619K 0.12% 136
2023
Q1 		$53.7M Buy
1,371,666
+21,352
+2% +$1.04M 0.16% 124
2022
Q4 		$71.4M Sell
1,350,314
-54,474
-4% -$2.65M 0.22% 114
2022
Q3 		$63.2M Buy
1,404,788
+57,544
+4% +$2.47M 0.21% 115
2022
Q2 		$49M Buy
1,347,244
+28,339
+2% +$1.03M 0.15% 131
2022
Q1 		$54.5M Buy
1,318,905
+39,628
+3% +$1.39M 0.14% 137
2021
Q4 		$54.5M Sell
1,279,277
-26,074
-2% -$1.3M 0.13% 146
2021
Q3 		$71.8M Buy
1,305,351
+21,305
+2% +$1.11M 0.17% 132
2021
Q2 		$61.5M Buy
1,284,046
+380,400
+42% +$19.4M 0.15% 138
2021
Q1 		$45.8M Buy
903,646
+32,464
+4% +$1.8M 0.12% 148
2020
Q4 		$54.9M Buy
871,182
+76,399
+10% +$4.74M 0.16% 132
2020
Q3 		$53.4M Buy
794,783
+344,465
+76% +$18.8M 0.19% 113
2020
Q2 		$18.9M Buy
450,318
+138,338
+44% +$5.31M 0.08% 160
2020
Q1 		$9.82M Buy
311,980
+87,446
+39% +$3.5M 0.06% 172
2019
Q4 		$9.07M Buy
224,534
+29,347
+15% +$1.03M 0.04% 188
2019
Q3 		$6.35M Buy
195,187
+51,986
+36% +$2.07M 0.03% 204
2019
Q2 		$6.94M Buy
+143,201
New +$6.09M 0.04% 199

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's SILK Position: Q4 2023 in Review

Kayne Anderson Rudnick Investment Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 456,778 shares — an estimated $6.85M sold.

Kayne Anderson Rudnick Investment Management first reported a position in SILK in Q2 2019 and held it in 18 quarters. The position peaked at $71.8M in Q3 2021. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Kayne Anderson Rudnick Investment Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 456,778 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $6.85M.
  • Kayne Anderson Rudnick Investment Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • Kayne Anderson Rudnick Investment Management's Silk Road Medical, Inc. Common Stock position peaked at $71.8M in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.